INTRODUCTION
p73 has been identified as a gene encoding a protein with significant identity with the tumour suppressor p53 [1] . p73 induces the expression of p53 target genes, such as p21, GADD45 (growth arrest and DNA damage 45) and MDM2 (murine double minute clone 2 oncoprotein), resulting in cell cycle arrest or apoptosis, when it is transiently expressed in cells [1] [2] [3] [4] .
However, unlike p53, mutations of p73 have not been found frequently in human tumour cells [5] . Some reports have suggested that p73 mRNA is overexpressed in tumour cells of hepatocellular carcinoma [6] , lung cancer [7] , breast cancer [8] , etc. p73-deficient mice have neurological, pheromonal and inflammatory defects, but lack spontaneous tumours, unlike p53-deficient mice [9] . These findings suggest that the physiological functions of p73 are different from those of p53.
The most marked structural difference between p73 and p53 is the additional C-terminal portion of p73. The presence of six isoforms, α, β, γ, δ, ε and ξ, with differing C-terminal structures has been reported [10] [11] [12] . Among these, only p73α has been found to have a C-terminal portion containing a region with a striking structural similarity with the SAM (sterile α motif ) domain [13, 14] , which is proposed to be a putative proteinprotein interaction domain [15] . The p73 isoforms are produced by alternative splicing. They vary in their transcriptional activity on p53-responsive promoters, and have different abilities to suppress cell growth [10, 11] . The pattern of expression of these p73 splicing variants also differs in cell lines and in normal human tissues [10, 11] . The different patterns of distribution of each variant in different cells and the differing abilities of each variant to transactivate p53-responsive genes suggest that each splicing variant has a different function.
Furthermore, the ability of each protein to regulate target genes may be achieved through the intermolecular association of Abbreviations used : p53BCS, p53-binding consensus sequence ; DBD, DNA-binding domain ; GADD45, growth arrest and DNA damage 45 ; MDM, murine double minute clone 2 oncoprotein ; OD, oligomerization domain. 1 To whom correspondence should be addressed (e-mail mhijikat!virus.kyoto-u.ac.jp).
variants interacted with each other, but not with p53. The transcriptional activity of p73β was reduced by co-expression with either p73α or p73ε, which bears an identical C-terminal structure to p73α. Co-expression of the C-terminal portion of p73α or p73ε with p73β also resulted in reduced transcriptional activity. Moreover, we observed that the level of endogenous p21 protein induced by p73β was decreased by co-expression of fulllength p73ε or the C-terminal region of p73α or p73ε. These observations suggest that p73-mediated gene expression is regulated by the interactions of p73 splicing variants in the cell.
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p73 variants, as suggested by the following findings. p53 functions as a tetramer [16, 17] , and the identity between the oligomerization domains (ODs) of p53 and p73 suggests that each p73 variant can form hetero-oligomers with p53 as well with as the other variants. In the yeast two-hybrid system, interactions between p73 and p53 or between p73 variants α, β, γ and δ have been reported [1, 11] . For example, p73α interacted weakly with p73β, whereas p73β showed strong homotypic interaction in the same system. However, in an immunoprecipitation assay of endogenous p73 proteins using a p73α-specific antibody, p73β was coimmunoprecipitated with p73α [18] . This suggested that at least some p73α forms a complex with p73β. Moreover, it was also reported that the purified recombinant polypeptide of the putative p73 OD (amino acids 345-383) associated with itself, although it did not interact with the p53 OD [19] . As the p73 OD used in that study is present in all p73 variants, it is likely that p73 variants can interact with each other. All of the above observations suggest that inter-variant association of p73 occurs and modulates transcriptional activity in the cell. Here, to test this possibility, we have examined the correlation between the transcriptional activities and the molecular interaction between the p73 splicing variants α, β, γ and ε.
MATERIALS AND METHODS

Plasmid construction
The expression plasmids pcDNA3-Myc-p73α, -p73β, -p73γ and -p73ε, p73α∆C424 and p73α∆C269 and pcDNA3-Myc-p53 were constructed by inserting the KpnI-BamHI fragment of a PCR product amplified by using pCMV-Tag1 (Stratagene) as template with S1 and R1 as primers (see below for primer sequences) into the KpnI-BamHI sites of pcDNA3-p73α, -p73β, -p73γ, -p73ε, p73α∆C424 and p73α∆C269 and pcDNA3-p53, which have been described previously [10] , to fuse the c-Myc epitope tag with the protein encoded by the expression plasmid. Plasmids pcDNA3-Myc-p73∆C566 and pcDNA3-Myc-p73∆C505 were generated by inserting the EcoRI-XhoI fragments of PCR products prepared by using pcDNA3-p73α as a template, with S2 and R2 as primers for p73α∆C566 and S2 and R3 as primers for p73α∆C505, into the EcoRI-XhoI site of pcDNA3-Myc-p73α. pcDNA3-Mycp73α∆OD, for expression of p73α lacking the putative OD, was constructed by inserting the EcoRI-MluI fragment of a PCR product amplified with primers S2 and R4, and the MluI-XhoI fragment of a PCR product amplified with primers S3 and R5 from pcDNA3-p73α as a template, into the EcoRI-XhoI site of pcDNA3-Myc-p73α. pcDNA3-FLAG-p73α, -p73β, -p73γ and -p73ε, and pcDNA3-FLAG-p53 (where the FLAG epitope has the sequence DYKDDDDK), were made by inserting the BamHI-XhoI fragments of pCMV-FLAG-p73α, -p73β, -p73γ and -p73ε, and pCMV-FLAG-p53 respectively (which have been described previously [10] ), into the BamHI-XhoI site of pcDNA3. pcDNA3-FLAG-p73α∆OD was constructed by inserting the EcoRI-XhoI fragment of pcDNA3-Myc-p73α∆OD into the EcoRI-XhoI site of pcDNA3-FLAG-p73α.
pcDNA3-αC, -βC, -γC and -εC were generated by inserting the BamHI-XhoI fragments of PCR products amplified by using pcDNA3-p73α, -p73β, -p73γ and -p73ε respectively as templates with primers S4 and R5 into the BamHI-XhoI site of pcDNA3. pcDNA3-αC∆N was constructed by inserting the EcoRI-XhoI fragment of a PCR product amplified by using pcDNA3-p73α as template with primers S5 and R5 into the EcoRI-XhoI site of pcDNA3. pcDNA3-αC∆C was generated by inserting the BamHI-XhoI fragment of a PCR product amplified by using Inter-variant regulation of p73 pcDNA3-p73α as template with primers S4 and R6 into the BamHI-XhoI site of pcDNA3.
pM-p73α, -p73β, -p73γ and -p73ε, and pVP16-p73α, -p73β, -p73γ and -p73ε were obtained by inserting the BamHI-SalI fragments of pcDNA3-p73α, -p73β, -p73γ and -p73ε respectively into the BamHI-SalI sites of pM and pVP16 (Clontech). pM-p53 and pVP16-p53 were generated by inserting the BamHI-SalI fragment of a PCR product amplified by using pcDNA3-p53 as a template with primers S6 and R7 into the BamHI-SalI sites of pM and pVP16 respectively.
The reporter plasmid pCAST2Bluc, in which the p53-binding consensus sequence (p53BCS) comprising two copies of 5h-GAGCATGCCCGGGCATGCTC-3h is located upstream of the luciferase gene [20] , was kindly provided by Dr Tohru Kiyono (Division of Virology, Aichi Cancer Center Research Institute, Nagoya, Japan). The reporter plasmid pFR-Luc, in which five tandem repeats of the GAL4 binding element are located upstream of the luciferase gene, was obtained from Stratagene.
The primers used in this experiment were as follows : S1, 5h-GACGGTACCCCACCATGGAGCAGAAACTCATC-3h ; S2, 5h-GGGACGGAATTCACCACCAT-3h ; S3, 5h-AATACGCG-TCAGCAGCAGCAGCTCCTAC-3h ; S4, 5h-AGAGGATCCA-GATGAACGAGAGCTCCGCCA-3h ; S5, 5h-GTCGAATTCA-TGCTGCCCTCCGTCAACCAG-3h ; S6, 5h-TTCGGATCCTT-GGCAGCCAGACTGCCTTC-3h ; R1, 5h-CCAGGATCCTCA-GATCCTCTTCAGA-3h ; R2, 5h-CAACCGAGTCAGTTGCT-AGAGCGGAGCAG-3h ; R3, 5h-CCTCTCGAGTCAGTTTG-GACACCCCAATCC-3h ; R4, 5h-AACACGCGTCTTCACAC-CGGCACCAAG-3h ; R5, 5h-ATTTAGGTGACACTATAG-3h ; R6, 5h-CCTCTCGAGTCAGTTTGGACACCCCAATCC-3h ; R7, 5h-AGAGTCGACCAGTGGGGAACAAGAAGTGG-3h.
Cell culture and transfection
Saos-2 and COS-7 cells were cultured in Dulbecco's modified Eagle's medium ( Nissui) with 10 % (v\v) fetal bovine serum and -glutamine. For plasmid transfection into the cells, we used the FuGENE6 transfection reagent (Boehringer Mannheim) according to the manufacturer's protocol.
Luciferase assay
Saos-2 cells were transfected with reporter plasmid pCAST2Bluc or pFR-Luc, together with an expression vector for the desired p73 derivative. At 30 h post-transfection, cells were lysed and the luciferase activity was quantified with a luciferase assay kit (Promega), as recommended by the manufacturer.
Western blotting analysis
The preparation of cell lysates, SDS\PAGE and immunoblotting analysis with a PVDF membrane were performed as described previously [21] . The antibodies used in these experiments were anti-c-Myc (9E10) (Santa Cruz Biotechnology), anti-[GAL4 DNA-binding domain (DBD)] (Clontech), anti-(FLAG M2) (Sigma), anti-p21 (C-19) (Santa Cruz Biotechnology) and anti-α-tubulin (Ab-1) (Calbiochem). Immunocomplexes on the filters were detected by enhanced chemiluminescence assay (Renaissance ; NEN).
Immunoprecipitation
Approx. 1i10& COS-7 cells were transfected in 3.5-cm wells with 0.5 µg of plasmid encoding Myc-tagged protein and 1.0 µg of plasmid encoding FLAG-tagged protein, and were harvested at 36 h post-transfection. Appropriate amounts of the lysate were used in this experiment to adjust the protein level for detection, because the level of production of each construct was different, as shown in Figure 1 (B). After cells were washed with cold PBS, they were lysed with 0.5 ml of RIPA buffer comprising 50 mM Tris\HCl ( pH 7.2), 150 mM NaCl, 1 % Triton X-100 and 0.5 % sodium deoxycholate. The lysates were pre-adsorbed with 30 µl of Protein G-Sepharose suspension (Pharmacia) for 30 min. After centrifugation (1930 g, 1 min, 4 mC), the supernatant was incubated with anti-c-Myc antibody (9E10) for 2 h. The immune complexes were recovered by adsorption to Protein G-Sepharose. The complexes were washed with 1 ml of RIPA buffer three times. The immunoprecipitates were dissolved in sample buffer comprising 125 mM Tris\HCl (pH 6.8), 4 % SDS, 150 mM 2-mercaptoethanol, 20 % glycerol and 0.01 % Bromophenol Blue, and boiled for 5 min. The samples were separated by SDS\7 % PAGE.
RESULTS
Modulation of the transcriptional activity of p73α by its Cterminal structure
We reported previously that the ability of p73α and p73ε to transactivate a transcriptional promoter with the p53BCS promoter was much weaker than that of p73β [10] . This suggested that the C-terminal structure that is shared by p73α and p73ε functions to suppress the transcriptional activities of these splicing variants of p73. It was reported that C-terminal deletion mutants of p73α showed higher transcriptional activity than wild-type p73α on p21, MDM2 and Bax promoters, and that the transcriptional activity was correlated with the DNA-binding activity [22] . However, the lower transcriptional activity of p73β, which has a level of DNA-binding activity comparable with that of the C-terminal deletion mutants of p73α, compared with these mutants suggests the existence of an alternative regulatory mechanism.
In order to avoid the effects of other transcription factors on the promoter, we conducted reporter assays using a reporter plasmid with a p53BCS promoter, in which only the p53BCS is used to analyse the transcriptional activity of the C-terminal deletion mutants of p73α with a Myc epitope tag, as shown in Figure 1 (A). We chose Saos-2 cells for this assay, as they are known to lack production of endogenous p53 and p73 proteins [10, 23] . Production of exogenous proteins of the expected size in Saos-2 cells transfected with the expression plasmids for these mutants was confirmed by Western blotting of cell lysates with anti-Myc antibody, although the production levels of these proteins were seen to vary to some extent ( Figure 1B) . As shown in Figure 1 (C), p73α∆C566 and p73α∆C505, in which the Cterminal 71 and 132 amino acids respectively of p73α were deleted, showed significantly higher transcriptional activity than wild-type p73α, as shown previously for the p21, MDM2 and Bax promoters [22] . The 71 amino acids deleted in p73α∆C566 are included in the shared region of p73α and p73ε, suggesting that this region is essential for the suppressive effects of these variants. The magnitude of activation by these deletion mutants of p73α was as high as that by p53 or p73β. With further Cterminal deletion ( p73α∆C424), the transactivation capacity was diminished. There was no positive correlation between the magnitude of reporter luciferase gene activation and the level of production of the respective p73 derivative, although there was an approximate inverse correlation, with the exception of p73α∆C505 (see Discussion). The differences in luciferase activity among the deletion mutants of p73α were not affected by titration of the amount of expression plasmid used for transfection (results not shown), as we have reported previously for p73 variants [10] . These results suggest that the differences in transcriptional activity found among the deletion mutants were not caused by their levels of expression. The lower activity of p73α∆C424 compared with that of p73α∆C505 may be due to the deletion of the second transcription activation domain, as reported by Takada et al. [24] .
To examine the mechanism of transcriptional suppression by the C-terminus of p73α, we investigated the subcellular localization of each p73 variant and of p73α∆C566. As reported previously, p73α and p73β were located mainly in the nucleus [2] . We found that p73γ, p73ε and p73α∆C566 were also located in the nucleus (results not shown), indicating that the varied transcriptional activities are not due to differences in subcellular localization.
Next we examined whether the level of transcriptional activity is dependent on the DBD of p73, as follows. We utilized a reporter assay based on the interaction between GAL4-binding elements and the GAL4 DBD. Four p73 splicing variants, which were fused with the GAL4 DBD at the N-terminus, were used as effector proteins, and pFR-Luc, which contains five repeats of the GAL4-binding elements upstream of the luciferase gene, was used as the reporter plasmid. In this system, transactivation through GAL4 DBD-based DNA binding of these fusion products was expected. We observed that the luciferase activities induced by p73α, p73γ and p73ε fused proteins were much weaker than that induced by the p73β fusion construct in Saos-2 cells ( Figure 1D ). This pattern of transcriptional activity of fused p73 variants was similar to that shown in Figure 1(C) , in which pCAST2Bluc was used as the reporter plasmid. The levels of production of these GAL4 DBD-fused p73 variants also showed a similar pattern to that of the Myc-tagged p73 shown in Figure 1(B) , indicating the lack of correlation between luciferase activity and the amount of each product. These results indicate that the difference in transactivation potential of these isoforms is not dependent on the DBD of p73.
Physical association between p73 splicing variants
To examine the homotypic and heterotypic interactions among p73 splicing variants in a co-immunoprecipitation assay, we Inter-variant regulation of p73
Figure 3 Suppression of transcriptional activity of p73β by co-expression of p73α or p73ε
Saos-2 cells were transfected with 0.2 µg of pCAST2Bluc and 0.5 µg of Myc-tagged p73β or p53 expression plasmid or empty vector (shown as v), together with increasing amounts (0, 0.1, 0.5 or 1.0 µg) of Myc-tagged p73α or p73α∆OD (p73α lacking the putative OD) expression plasmid (A), or 1 µg of Myc-tagged p73α, p73β, p73γ or p73ε or empty vector (B). The total amount of plasmid DNA used for transfection was adjusted to 1.7 µg by adding an appropriate amount of empty vector. The lower panels show the results of Western blot analysis of whole-cell extracts for detection of Myc-tagged protein production. The data from the luciferase assay were analysed essentially as described in the legend to Figure 1. constructed mammalian expression plasmids in which the FLAG epitope tag or Myc epitope tag sequence was introduced at the N-terminus of p73α, p73β, p73γ, p73ε, p53 and p73α∆OD, which is a deletion mutant of p73α lacking the putative OD. We confirmed that these FLAG-and Myc-tagged products also induced the transcription of the reporter gene of pCAST2Bluc similarly to the authentic proteins in Saos-2 cells (results not shown). We then performed co-immunoprecipitation experiments using extracts of COS-7 cells transiently expressing various combinations of FLAG-tagged and Myc-tagged constructs. We found that all FLAG-tagged p73 variants were detected by Western blotting using the anti-FLAG antibody to probe immunoprecipitates, which were pulled down with anti-Myc antibody and contained each Myc-tagged p73 variant ( Figure  2A ). In contrast, p53 did not co-immunoprecipitate with p73α or p73β. These results indicated that p73 variants interact with each other, but not with p53. Furthermore, we found that p73α∆OD was co-precipitated with p73α, but not with p73β. These results suggested that p73α interacts with p73β through the putative OD of p73, but that homotypic interactions of p73α may occur through another domain as well.
We also investigated the interactions between p73 variants using the two-hybrid system in mammalian cells. As shown in Figure 2 (B), reporter gene expression was activated to some extent with all combinations of a GAL4 DBD-fused p73 variant and a VP16 transactivation domain-fused p73 variant. On the other hand, activation due to interactions between p53 and p73 variants was not detected in this system, in agreement with the results in Figure 2 (A). In this experiment, however, we observed that only a low level of reporter gene activation was induced through the interaction with p73α or p73ε derivatives used as either bait or prey (see the scale of the ordinate of Figure 2B ; lanes 9-12, 15-18, 27, 30, 33 and 36). As shown in Figure 2 (A), p73α and p73ε are relatively better partners for complexformation with any isoforms, whereas p73β and p73γ appear to Figure  4A ), and the cell extracts were analysed. The fold increase in the p21 protein level, which was quantified relative to the level in cells transfected with the pcDNA3 vector (v) by densitometry, is shown below the top panels in (A) and (B). (C) Effects of co-expression of p73α and p73ε on p53-induced endogenous p21 protein levels. The effects of production of p73α, p73ε, αC and εC on the induction of p21 protein by Myc-p53 were analysed. Transfection experiments were performed with 0.5 µg of pcDNA3-Myc-p53 and 1.0 µg of expression plasmid for p73α, p73ε, αC or εC (see Figure 4A ). The negative control experiments were done by using empty vector (v) instead of the expression plasmid.
be poorer partners, as indicated by the band intensities. Although stronger association (such as that provided by p73α and p73ε) normally results in more potent transactivation in mammalian two-hybrid systems, the weaker association provided by p73β and p73γ resulted in more potent transactivation in the present case. This implies that p73α and p73ε have repressive activity against the VP16 transactivation domain. Moreover, in Figure 1 , we showed that p73α and p73ε have much lower transactivation activities not only for the p53BCS promoter but also for the promoter that contains GAL4-binding elements. Based on these findings, we conclude that p73 variants α, β, γ and ε interact with each other, but not with p53.
Suppression of the transcriptional activity of p73β by p73α or p73ε
It was reported recently that the C-terminal region of p73α (amino acids 327-636) bound to p73α and p73β in itro and blocked p73-dependent transcriptional activation and apoptosis in Saos-2 cells [25] . To examine whether wild-type p73α influences the transcriptional activity of p73β, which has much stronger activity than p73α, a reporter gene assay using pCAST2Bluc as a reporter plasmid was performed under conditions whereby p73α was expressed simultaneously with p73β. When p73α was co-expressed with p73β, activation of the reporter gene was markedly reduced compared with the level seen in cells producing p73β alone ( Figure 3A , lanes 5-8), suggesting that p73α suppressed the transcriptional activity of p73β. The suppression was dependent on the dose of p73α expression plasmid. As the level of production of p73β was seen to be increased by coexpression with p73α, the suppressive effect was not due to a decreased amount of p73β. No transcription-suppressing effect of p73α was observed when p73α was co-expressed with p53 ( Figure 3A, lanes 9-12) , or p73α∆OD with p73β (lanes 13-16).
Since neither p53 nor p73α∆OD interacts with p73β (Figure 2A ), these findings suggest that the transcriptional suppression by p73α occurs through interaction with p73β. On the other hand, we also observed that p53-dependent reporter gene expression was augmented by co-expression of p73α ( Figure 3A , lanes 10-12). Since no interaction was detected between p73α and p53 in the immunoprecipitation assay or two-hybrid assay, it seems that p73α activates transcription by p53 indirectly. We next investigated whether p73γ and p73ε also affect the transcriptional activity of p73β. p73γ had little suppressive effect on the transcriptional activity of p73β ( Figure 3B, lane 5) . On the other hand, p73ε, like p73α, repressed the transcriptional activity of p73β ( Figure 3B, lane 6) . Augmentation of the transcriptional activation of p53 by co-expression of p73ε, as well as of p73α, was observed ( Figure 3B, lanes 8 and 11) . These results suggest that p73α and p73ε suppress the transactivation ability of p73β by interacting with it. Therefore it seems that the transcriptional activity of p73 is regulated by interactions among p73 variants, and that the functions of p73 molecules will be determined by the expression pattern of p73 variants in cells.
Transcriptional suppression by the C-terminal structure of p73α and p73ε
In order to confirm that the C-terminal region of p73ε, as well as of p73α, which was reported to be a dominant-negative p73 mutant [25] , plays a role in the transcriptional repression of p73β through molecular interactions, the effect of the C-terminal region of each variant on the transcriptional activity of p73β was examined using a reporter gene assay using pCAST2Bluc ( Figure  4A ). Co-transfection of the expression plasmids for the Cterminal region of p73ε, and of p73α, with p73β resulted in a decrease in luciferase activity ( Figure 4B, lanes 3 and 8) . However, co-production of βC, γC, αC∆C or αC∆N (which is the Cterminal region without the OD) did not have a repressive effect on p73β ( Figure 4B, lanes 4-7) . As we confirmed that p73β interacted with αC and εC, but not with αC∆N, in co-immunoprecipitation experiments (results not shown), it is likely that αC and εC suppress the transcriptional activation of p73β through interaction with it.
Suppression of the p73β-induced increase in endogenous p21 protein by co-expression of p73ε, but not p73α
To examine whether transcriptional regulation of endogenous gene expression by p73 variants is observed, we investigated the levels of production of p21 protein in Saos-2 cells by immunoblotting after transfection with expression plasmids encoding Myc-tagged p73 variants and p53. As expected from the results of a previous study [3] , p73α induced p21 production to the same extent as p73β ( Figure 5A ), in contrast with the results of the reporter gene assay in Figure 1(C) . This may imply that transactivation of endogenous genes by p73α is regulated through complicated interactions with other transcription factors. We also observed that p73γ induced p21 gene expression. However, p73ε did not increase the p21 protein level, consistent with the results of the reporter gene assay using the p53BCS promoter. Moreover, we observed that the level of p21 protein induced by p73β was reduced by co-expression of p73ε ( Figure 5B, lane 6) . This suppression appeared to be exerted by the C-terminal portion of p73ε (p73εC) ( Figure 5B, lane 10) . p73αC also had a suppressive effect on p21 induction by p73β ( Figure 5B, lane 7) , although full-length p73α and αC∆N had no effect ( Figure 5B,  lanes 3 and 11) . On the other hand, p73ε, εC and αC did not suppress the induction of p21 expression by p53 ( Figure 5C ). These observations suggest that p73-mediated gene expression is regulated by the mutual interactions of its splicing variants in the cell.
DISCUSSION
We reported previously that transactivation of the p53BCS promoter by p73α and p73ε was much weaker than that by p73β [10] . In the present study, we show that p73α and p73ε have the potential to suppress the transcriptional activity of p73β through their C-terminal regions in trans (Figure 3 and 4) . The fact that C-terminal deletion mutants of p73α showed significantly higher transcriptional activity than wild-type p73α (Figure 1) suggests that the C-terminal structure of p73α also suppresses the activity of this transcription in cis ([22] and the present paper). As the Cterminal 110 amino acids of p73α (positions 527-636) are shared by p73ε (positions 446-555), this structure is likely to have an important role in the suppressive effects of these variants both in cis and in trans.
The transcriptional activity of p73 in the cells seems to be regulated in a more complex manner. Lower transcriptional activity of p73α compared with p73β has been shown for expression of the endogenous MDM2 and GADD45 genes [3] . As shown in Figure 5 , however, p73α induced the gene expression of p21 to the same extent as p73β, as reported previously [3] . Similar results were obtained with reporter assay systems using reporter plasmids containing the promoter of the MDM2 or p21 gene upstream of the luciferase gene (results not shown). This suggests that the ability of the C-terminus of p73α to repress transcription is ineffective for the promoter of the p21 gene. In contrast with p73α, the level of induction of p21 by p73ε was quite low, as was the activity in the reporter assay using pCAST2Bluc. This suggests that the mechanism of transcriptional regulation by p73ε is different from that by p73α.
We demonstrated some quantitative differences among the exogenous p73 variants and mutants expressed in Saos-2 cells ( Figures 1B, 3A, 3B, 5A and 5B). There was an approximate inverse correlation between expression level and transcriptional potency for the p73 variants and deletion mutants, except for p73α∆C505 ( Figure 1B) . Moreover, the level of production of p73β was seen to be increased by co-expression with p73α ( Figure 3A, lanes 5-8) , and the amount of p73α was conversely reduced by co-expression with p73β ( Figure 3A , lanes 5-8, compare with the expression of p73α alone, lanes 1-4). Based on these observations, it is suggested that a gene that is responsible for the degradation of p73s may be a target of p73β. This is by analogy with p53, which is degraded by MDM2, whose gene is transcriptionally activated by p53 [26, 27] .
In the present study, the results of immunoprecipitation assays and two-hybrid assays in mammalian cells showed that four p73 variants, p73α, p73β, p73γ and p73ε, interact with each other. Moreover, it was suggested that the transcriptional activity of each p73 splicing variant is regulated by interactions among the variants. These results indicate that the level of induction of p73-responsive gene expression was low when p73ε (and p73α in some cases) was produced at high levels, even in the presence of p73β. It has also been reported that ∆N-p73 ( p73 lacking the Nterminal region) in mice produced from an alternative promoter such as ∆N-p63 [28] suppressed the transcriptional activity of p73α [9] . This suggests that regulation of the function of p73 by inter-variant associations is a physiologically significant event. Therefore the pattern of expression of p73 variants, as well as the level of expression of a given p73 variant, seems to be important for the function of the p73 gene. It has been reported that the mRNA expression pattern of p73 variants differs in normal human tissues and cell lines [10, 11] . The differential expression of p73 variants in ovarian tumours was also reported [29] . Although inactivation of p73 due to alterations in the p73 gene has not been detected frequently in human cancer cells, changes in the pattern of expression of p73 variants can modify the expression of p73 target genes, and such modifications may contribute to the development of cancer. Therefore, to investigate the contribution of p73 to cancer development, DNA damage, cell differentiation, etc., the pattern of expression of p73 variants, as well as the total level of expression and mutation of the p73 gene, should be taken into consideration.
With regard to the mechanism of transcriptional suppression by the C-terminal region of p73α and p73ε, it was reported recently that the DNA-binding activity of C-terminal deletion mutants of p73α for the p53-responsive element was higher than that of wild-type p73α, and that the difference in DNA-binding activity reflected the difference in transcriptional activity between these mutants and the wild type [22] . In the present experiments, the transcriptional activity of p73α and p73ε fused with the GAL4 DBD on the promoter containing GAL4-responsive elements was also much weaker than that of p73β ( Figure 1D ), indicating that the difference in transactivation potential of these variants is independent of the DBD of p73. These results suggested two possible mechanisms for the transcriptional activities of p73 splicing variants : one is that the C-terminal regions of p73α and p73ε affected the DNA-binding capacity of the respective GAL4 DBD-fused proteins to the GAL4-responsive element ; and the other is that some novel mechanism, in addition to the differences in DNA-binding activity, results in the transcriptional suppression. In order to elucidate the mechanism, we are now investigating the DNA-binding activity of p73 variants to p53BCS and the GAL4 DBD. Investigation of the mechanism of transcriptional regulation by the C-terminus of p73 may yield new insights into the regulatory machinery of transcription.
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